SNOA
HEALTHCARESonoma Pharmaceuticals Inc
$1.19-0.04 (-3.25%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving SNOA Today?
No stock-specific AI insight has been generated for SNOA yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$0.85$6.92
$1.19
Fundamentals
Market Cap$5M
P/E Ratio—
EPS$-1.95
Dividend Yield—
Dividend / Share—
ROE-0.8%
Profit Margin-0.2%
Debt / Equity—
Trading
Volume104K
Avg Volume (10D)—
Shares Outstanding3.9M
SNOA News
20 articles- Sonoma Pharmaceuticals Announces Pricing of $4 Million Public OfferingYahoo Finance·Apr 24, 2026
- Sonoma Pharmaceuticals Announces U.S. Retail Launch of Advanced Burn Relief Hydrogel in CVS and WalmartYahoo Finance·Mar 24, 2026
- Sonoma Pharmaceuticals Announces Launch of New Dermatology Product Line under Person & Covey's Aquanil Brand for Sensitive SkinYahoo Finance·Mar 18, 2026
- Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2026 Financial ResultsYahoo Finance·Feb 10, 2026
- Sonoma Pharmaceuticals Welcomes New Member of its Board of Directors and New Senior Vice President of Regulatory, Quality and Product DevelopmentYahoo Finance·Jan 28, 2026
- National Rosacea Society Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn AdvancedYahoo Finance·Nov 13, 2025
- Sonoma Pharmaceuticals to Exhibit at MEDICA 2025 in DüsseldorfYahoo Finance·Nov 6, 2025
- Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2026 Financial ResultsYahoo Finance·Nov 4, 2025
- Sonoma Pharmaceuticals and Medline Industries Launch New HOCl Wound Cleanser for U.S. HospitalsYahoo Finance·Oct 14, 2025
- Sonoma Pharmaceuticals Expands Market Reach with FDA Cosmetic Product Facility Registration and Microcyn-Based Cosmetic Product Listing Under MoCRAYahoo Finance·Oct 7, 2025
- Sonoma Pharmaceuticals to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025Yahoo Finance·Sep 25, 2025
- National Psoriasis Foundation Awards Seal of Recognition to Sonoma Pharmaceuticals for Reliefacyn AdvancedYahoo Finance·Aug 26, 2025
- Despite Fast-paced Momentum, Sonoma Pharmaceuticals (SNOA) Is Still a Bargain StockYahoo Finance·Aug 19, 2025
- Sonoma Pharmaceuticals Soars 95% After Walmart, Amazon Retail DebutYahoo Finance·Aug 14, 2025
- BC-Most Active StocksYahoo Finance·Aug 14, 2025
- Sonoma Pharmaceuticals Announces Launch of Diaper Rash Product in Walmart and other U.S. ChainsYahoo Finance·Aug 13, 2025
- Sonoma Pharmaceuticals Reports First Fiscal Quarter 2026 Financial ResultsYahoo Finance·Aug 7, 2025
- Sonoma Pharmaceuticals (SNOA) Is Attractively Priced Despite Fast-paced MomentumYahoo Finance·Jul 14, 2025
- The early winner in the 'Dexit' war for corporate relocations: NevadaYahoo Finance·Jul 10, 2025
- Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2025 Financial ResultsYahoo Finance·Jun 17, 2025
All 20 articles loaded
Price Data
Open$1.16
Previous Close$1.23
Day High$1.24
Day Low$1.12
52 Week High$6.92
52 Week Low$0.85
52-Week Range
$0.85$6.92
$1.19
Fundamentals
Market Cap$5M
P/E Ratio—
EPS$-1.95
Dividend Yield—
Dividend / Share—
ROE-0.8%
Profit Margin-0.2%
Debt / Equity—
Trading
Volume104K
Avg Volume (10D)—
Shares Outstanding3.9M
About Sonoma Pharmaceuticals Inc
Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for various applications, including wound care, animal health care, eye care, oral care, and dermatological conditions in the United States and internationally. The company is headquartered in Woodstock, Georgia.
HEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICDRUG MANUFACTURERS - SPECIALTY & GENERIC
CIK—
Composite FIGI—
Share Class FIGI—